CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio

Latest as of March 2026: 5.64%

CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 5.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 300765 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥350.30 Million
≈ $51.26 Million USD Cash + Short-term Investments

Total Assets

CN¥6.21 Billion
≈ $908.72 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. See net asset quality index of CSPC Innovation Pharmaceutical Co Ltd Cl to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CSPC Innovation Pharmaceutical Co Ltd Cl market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥350.30 Million 5.64%
Total Liquid Assets CN¥350.30 Million 5.64%

Asset Resilience Insights

  • Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 5.64% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Nestle India Limited
NSE:NESTLEIND
Packaged Foods 1.07%
Inner Mongolia Yili Industrial Group Co Ltd
SHG:600887
Packaged Foods 0.19%
Saputo Inc
TO:SAP
Packaged Foods 3.36%
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
Packaged Foods 2.23%
Orkla ASA
OL:ORK
Packaged Foods 4.19%
Hanil Feed Co. Ltd
KQ:005860
Packaged Foods 7.00%
Lotus Bakeries
BR:LOTB
Packaged Foods 2.28%
The a2 Milk Company Ltd
AU:A2M
Packaged Foods 24.93%

Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.14% CN¥385.39 Million
≈ $56.39 Million
CN¥6.28 Billion
≈ $918.42 Million
-1.67pp
2024-12-31 7.81% CN¥470.09 Million
≈ $68.79 Million
CN¥6.02 Billion
≈ $881.22 Million
-3.25pp
2021-12-31 11.06% CN¥413.59 Million
≈ $60.52 Million
CN¥3.74 Billion
≈ $547.46 Million
+0.17pp
2020-12-31 10.89% CN¥321.94 Million
≈ $47.11 Million
CN¥2.96 Billion
≈ $432.64 Million
-22.77pp
2019-12-31 33.66% CN¥960.09 Million
≈ $140.49 Million
CN¥2.85 Billion
≈ $417.39 Million
--
pp = percentage points

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods
Market Cap
$4.92 Billion
CN¥33.64 Billion CNY
Market Cap Rank
#3658 Global
#545 in China
Share Price
CN¥23.95
Change (1 day)
-2.60%
52-Week Range
CN¥23.23 - CN¥58.32
All Time High
CN¥189977.21
About

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more